Glenn Pierce - Net Worth and Insider Trading

Glenn Pierce Net Worth

The estimated net worth of Glenn Pierce is at least $184,762 dollars as of 2024-06-07. Glenn Pierce is the Director of Voyager Therapeutics Inc and owns about 21,788 shares of Voyager Therapeutics Inc (VYGR) stock worth over $184,762. Details can be seen in Glenn Pierce's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Glenn Pierce has not made any transactions after 2022-07-14 and currently still holds the listed stock(s).

Transaction Summary of Glenn Pierce

To

Glenn Pierce Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Glenn Pierce owns 2 companies in total, including Global Blood Therapeutics Inc (GBT) , and Voyager Therapeutics Inc (VYGR) .

Click here to see the complete history of Glenn Pierce’s form 4 insider trades.

Insider Ownership Summary of Glenn Pierce

Ticker Comapny Transaction Date Type of Owner
GBT Global Blood Therapeutics Inc 2016-02-08 director
VYGR Voyager Therapeutics Inc 2022-07-14 director

Glenn Pierce Latest Holdings Summary

Glenn Pierce currently owns a total of 1 stock. Glenn Pierce owns 21,788 shares of Voyager Therapeutics Inc (VYGR) as of July 14, 2022, with a value of $184,762.

Latest Holdings of Glenn Pierce

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VYGR Voyager Therapeutics Inc 2022-07-14 21,788 8.48 184,762

Holding Weightings of Glenn Pierce


Glenn Pierce Form 4 Trading Tracker

According to the SEC Form 4 filings, Glenn Pierce has made a total of 1 transactions in Voyager Therapeutics Inc (VYGR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Voyager Therapeutics Inc is the sale of 9,512 shares on July 14, 2022, which brought Glenn Pierce around $63,730.

Insider Trading History of Glenn Pierce

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Glenn Pierce Trading Performance

GuruFocus tracks the stock performance after each of Glenn Pierce's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Glenn Pierce is -39.92%. GuruFocus also compares Glenn Pierce's trading performance to market benchmark return within the same time period. The performance of stocks bought by Glenn Pierce within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Glenn Pierce's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Glenn Pierce

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -13.33 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -9.11 LIMIT LIMIT LIMIT LIMIT LIMIT

Glenn Pierce Ownership Network

Ownership Network List of Glenn Pierce

No Data

Ownership Network Relation of Glenn Pierce

Insider Network Chart

Glenn Pierce Owned Company Details

What does Global Blood Therapeutics Inc do?

Who are the key executives at Global Blood Therapeutics Inc?

Glenn Pierce is the director of Global Blood Therapeutics Inc. Other key executives at Global Blood Therapeutics Inc include Chief Financial Officer Jeffrey S Farrow , See Remarks Nazila Habibizad , and Chief Human Resources Officer Carrie Krehlik .

Global Blood Therapeutics Inc (GBT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Global Blood Therapeutics Inc Insider Transactions

No Available Data

Glenn Pierce Mailing Address

Above is the net worth, insider trading, and ownership report for Glenn Pierce. Currently GuruFocus does not have mailing address information for Glenn Pierce.

Discussions on Glenn Pierce

No discussions yet.